No insider purchase over the last 90 days. The latest, by 祝方猛, was filed 17 May 2022.
Apeloa Pharmaceutical Co.,Ltd: what insiders have been doing
Apeloa Pharmaceutical Co.,Ltd belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). Apeloa Pharmaceutical Co.,Ltd has had no insider filing for more than a year; the last one goes back to 25 April 2023.
Our records for Apeloa Pharmaceutical Co.,Ltd go back to 2022, with 1 purchase and 1 sale on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Since the insiders bought
- -18.6%Entry CN¥23.55 · Close at T+365 CN¥19.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Apeloa Pharmaceutical Co.,Ltd
普洛药业 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the research, development, and production of innovative medications.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
